| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.33 | 3e-10 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.33 | 6e-10 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.2 | 8e-09 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.3 | 9e-09 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-08 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.3 | 7e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.17 | 7e-08 |